Key statistics
On Saturday, OS Therapies Inc (OSTX:ASQ) closed at 2.85, 13.55% above the 52 week low of 2.51 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.87 |
---|---|
High | 2.94 |
Low | 2.67 |
Bid | 2.75 |
Offer | 3.08 |
Previous close | 2.81 |
Average volume | 15.60k |
---|---|
Shares outstanding | 20.05m |
Free float | 15.07m |
P/E (TTM) | -- |
Market cap | 57.14m USD |
EPS (TTM) | -0.3011 USD |
Data delayed at least 15 minutes, as of Nov 09 2024 01:00 GMT.
More ▼
- OS Therapies to Present at The Spartan Capital Investor Conference
- Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30
- OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
- OS Therapies to Present at the LD Micro Main Event XVII
- OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
- OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit
- OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates
- OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference
- OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose
- OS Therapies Appoints Borys Shor, PhD to ADC Advisory Board
More ▼